Evotec stock faces decisive test as full results approach

Published on 11/04/2026 at 12:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Evotec stock heads into Thursday's results with preliminary figures above market expectations. The full-year outlook is unchanged.

What Investors Will Watch Next

Evotec expects first-nine-month revenue of 465.0 million euros and adjusted EBITDA of minus 42.8 million euros.
Management reaffirmed its 2026 revenue and adjusted EBITDA outlook.
Full third-quarter and nine-month results are scheduled for November 5.

Evotec SE, DE0005664809, Illustration mit AI erstellt.

Evotec SE will publish its full third-quarter and nine-month results for 2026 on Thursday, November 5, after preliminary figures came in above market expectations. The company announced the preliminary, unaudited figures on October 13 and reaffirmed its full-year outlook.

Preliminary Beat Still Leaves Loss

For the first nine months of 2026, Evotec expects group revenue of 465.0 million euros and adjusted group EBITDA of minus 42.8 million euros. The company said both figures were above current market expectations, with the variance driven largely by the timing of consensus estimates.

The result is positive relative to expectations but does not represent a return to adjusted operating profit. Evotec's adjusted EBITDA remained negative on a preliminary basis, leaving the complete report to clarify the quarterly contribution and the composition of the nine-month performance.

Evotec also retained its 2026 guidance. The company expects group revenue of 570 million to 610 million euros, or 595 million to 635 million euros at constant exchange rates. Adjusted group EBITDA is guided at minus 70 million to minus 105 million euros, or minus 60 million to minus 90 million euros at constant exchange rates.

The preliminary release and its outlook are set out in Evotec's company announcement. The retained forecast means that the November 5 report will be judged not only against consensus expectations, but also against management's existing loss and revenue ranges.

Results Set The Next Test

The real-time quote of Evotec stock traded at 2.89 euros on Lang & Schwarz at 11:57 CET on Wednesday, November 4, 2026. No Xetra comparison is included because the applicable Xetra closing price could not be established.